LabCorp Acquires MNG Laboratories from HealthEdge
March 4, 2019
LabCorp has acquired MNG Laboratories, an Atlanta-based clinical diagnostic provider specializing in neurogenetics and next-generation sequencing, from HealthEdge Investment Partners' Fund II. The acquisition expands LabCorp’s neurology and neurogenetics testing capabilities and makes MNG’s testing services available through LabCorp’s Covance drug development business.
- Buyers
- LabCorp
- Targets
- MNG Laboratories
- Sellers
- HealthEdge Investment Partners
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.